Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
A 34-year study links early weight loss in prediabetes to lower cardiovascular risks. Explore the findings and what they mean for prevention.
Read More »Lose 5% Now, Benefit Decades Later? Prediabetes Data Point to a Possible Legacy Effect
The Immune Target Moved, but the Diabetes Didn’t: What a Failed Type 1 Trial Can Teach Us
Interleukin-2 boosted immune cells but failed to preserve insulin production in the DIABIL-2 trial. Discover what this means for type 1 diabetes.
Read More »High-Fiber Diet vs. Metformin: A Small Trial Delivers a Surprising Result
A small 84-day trial found greater A1C and BMI improvements with a high-fiber diet than metformin. Explore the results, limitations, and clinical implications.
Read More »After DKA or Repeated Low Blood Sugar, Could Attention Problems Linger?
Explore how hypoglycemia and DKA may be linked to attention difficulties in children with type 1 diabetes and what new research reveals.
Read More »Metformin in Pregnancy: What Happens to Children Years Later?
What happens to children exposed to metformin during pregnancy? A study of more than 177,000 children offers reassuring developmental findings.
Read More »Could Fenofibrate Slow Diabetic Eye Disease in Type 1 Diabetes?
Can fenofibrate slow diabetic retinopathy in type 1 diabetes? Explore new LENS trial research, potential benefits, safety, and clinical implications.
Read More »Quit Smoking, Protect More Than Your Heart: When Diabetes Complication Risk Starts to Fall
New research links smoking cessation to lower diabetes complication risks. Explore what the findings mean for kidney, eye, and nerve health.
Read More »Why Are ADHD and Autism Showing Up More Often in Young People With Type 2 Diabetes?
New EASD research links neurodiversity and type 2 diabetes in younger people, highlighting ADHD, autism, and the need for tailored diabetes care.
Read More »Type 1 Diabetes Care Just Changed: The 2026 ADA/EASD Update Clinicians Need to Know
The type 1 diabetes consensus 2026 expands guidance on AID, cardiovascular risk, obesity, complications, psychosocial care, and new therapies.
Read More »Pump or Smart Pen? A Head-to-Head Trial Finds There May Be More Than One Right Answer
A head-to-head trial compared a smart insulin pen vs AID in adults with type 1 diabetes. See who benefited most and why patient preference still matters.
Read More »